Cohen JM - Search Results

1

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.

Ferrari MD, Diener HC, Ning X, Galic M, Cohen JM, Yang R, Mueller M, Ahn AH, Schwartz YC, Grozinski-Wolff M, Janka L, Ashina M. Ferrari MD, et al. Among authors: cohen jm. Lancet. 2019 Sep 21;394(10203):1030-1040. doi: 10.1016/S0140-6736(19)31946-4. Epub 2019 Aug 16. Lancet. 2019. PMID: 31427046 Clinical Trial.

2

Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.

Cohen JM, Dodick DW, Yang R, Newman LC, Li T, Aycardi E, Bigal ME. Cohen JM, et al. Headache. 2017 Oct;57(9):1375-1384. doi: 10.1111/head.13156. Epub 2017 Sep 1. Headache. 2017. PMID: 28862758 Clinical Trial.

3

Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.

Silberstein SD, McAllister P, Ning X, Faulhaber N, Lang N, Yeung P, Schiemann J, Aycardi E, Cohen JM, Janka L, Yang R. Silberstein SD, et al. Among authors: cohen jm. Headache. 2019 Jun;59(6):880-890. doi: 10.1111/head.13534. Epub 2019 Apr 12. Headache. 2019. PMID: 30977520

4

Physician and patient preferences for dosing options in migraine prevention.

Cowan R, Cohen JM, Rosenman E, Iyer R. Cowan R, et al. Among authors: cohen jm. J Headache Pain. 2019 May 9;20(1):50. doi: 10.1186/s10194-019-0998-8. J Headache Pain. 2019. PMID: 31072307 Free PMC article.

5

Fremanezumab for the preventive treatment of migraine.

Silberstein SD, Cohen JM, Yeung PP. Silberstein SD, et al. Among authors: cohen jm. Expert Opin Biol Ther. 2019 Aug;19(8):763-771. doi: 10.1080/14712598.2019.1627323. Epub 2019 Jul 1. Expert Opin Biol Ther. 2019. PMID: 31177856 Clinical Trial.

6

Effect of fremanezumab on quality of life and productivity in patients with chronic migraine.

Lipton RB, Cohen JM, Gandhi SK, Yang R, Yeung PP, Buse DC. Lipton RB, et al. Among authors: cohen jm. Neurology. 2020 Aug 18;95(7):e878-e888. doi: 10.1212/WNL.0000000000010000. Epub 2020 Aug 3. Neurology. 2020. PMID: 32747522 Free PMC article.

7

Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine.

Friedman DI, Cohen JM. Friedman DI, et al. Among authors: cohen jm. Emerg Top Life Sci. 2020 Sep 8;4(2):179-190. doi: 10.1042/ETLS20200018. Emerg Top Life Sci. 2020. PMID: 32832978 Free PMC article. Review.

8

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study.

Buse DC, Gandhi SK, Cohen JM, Ramirez-Campos V, Cloud B, Yang R, Cowan RP. Buse DC, et al. Among authors: cohen jm. J Headache Pain. 2020 Sep 4;21(1):109. doi: 10.1186/s10194-020-01177-4. J Headache Pain. 2020. PMID: 32887548 Free PMC article.

9

Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study.

Goadsby PJ, Silberstein SD, Yeung PP, Cohen JM, Ning X, Yang R, Dodick DW. Goadsby PJ, et al. Among authors: cohen jm. Neurology. 2020 Nov 3;95(18):e2487-e2499. doi: 10.1212/WNL.0000000000010600. Epub 2020 Sep 10. Neurology. 2020. PMID: 32913018 Free PMC article. Clinical Trial.

10

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.

Silberstein SD, Cohen JM, Seminerio MJ, Yang R, Ashina S, Katsarava Z. Silberstein SD, et al. Among authors: cohen jm. J Headache Pain. 2020 Sep 21;21(1):114. doi: 10.1186/s10194-020-01173-8. J Headache Pain. 2020. PMID: 32958075 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

627 results

Search Page